GB001 in Adult Participants With Chronic Rhinosinusitis

NCT03956862 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Interventions

DRUG: GB001
DRUG: Placebo

Sponsor

GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.